Vaxart, Inc.

VXRT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Jun 26, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEFA14A Jun 26, 2026 DEFINITIVE ADDITIONAL MATERIALS
DFAN14A Jun 22, 2026
DEFA14A Jun 16, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEFA14A Jun 16, 2026 DEFINITIVE ADDITIONAL MATERIALS
DFAN14A Jun 9, 2026
DEFA14A Jun 8, 2026 DEFINITIVE ADDITIONAL MATERIALS
DFAN14A Jun 8, 2026
DEFA14A Jun 8, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEFC14A Jun 4, 2026
DEFA14A Jun 1, 2026 DEFINITIVE ADDITIONAL MATERIALS
ARS Jun 1, 2026 ARS
DEFA14A Jun 1, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEFA14A Jun 1, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEFC14A Jun 1, 2026 PROXY STATEMENT
PRER14A May 29, 2026 PROXY STATEMENT
PRRN14A May 29, 2026
4 May 26, 2026 FORM 4
PREC14A May 21, 2026
4 May 21, 2026 FORM 4
DEFA14A May 20, 2026 SOLICITING MATERIAL PURSUANT TO 240.14A-12
DEFA14A May 20, 2026 SOLICITING MATERIAL PURSUANT TO 240.14A-12
PREC14A May 19, 2026 PROXY STATEMENT
DEFA14A May 19, 2026 CURRENT REPORT
8-K May 19, 2026 CURRENT REPORT
← Newer Page 2 of 65 · 1612 filings Older →